STEERlife & Callidus Partner for Drug Development
By Rediff Money Desk, New Delhi Nov 13, 2024 18:47
STEERlife and Callidus Research Laboratories join forces to accelerate drug development for global markets, combining hot melt extrusion and pharmaceutical expertise.
New Delhi, Nov 13 (PTI) STEERlife and Callidus Research Laboratories have joined hands to accelerate drug development for global markets, the companies said in a joint statement.
The collaboration combines STEERLife's advanced hot melt extrusion and continuous processing technologies with Callidus' pharmaceutical drug development expertise, addressing the global demand for innovative drug formulations and development, the statement said.
The partnership enables both organisations to integrate their specialised knowledge and skills, yielding innovative solutions and enhanced product offerings, it stated.
The tie-up also enables end-to-end drug development for APIs (active pharmaceutical ingredients).
"This collaboration empowers clients with cutting-edge technologies, extensive product development expertise, and seamless scale-up capabilities," STEERLife CEO Indu Bhushan said.
The alliance exemplifies dedication to pushing boundaries, fostering growth and improving patient outcomes through transformative pharmaceutical solutions, Callidus Research Laboratories Co-founder & Director Vardhaman Bafna said.
The collaboration combines STEERLife's advanced hot melt extrusion and continuous processing technologies with Callidus' pharmaceutical drug development expertise, addressing the global demand for innovative drug formulations and development, the statement said.
The partnership enables both organisations to integrate their specialised knowledge and skills, yielding innovative solutions and enhanced product offerings, it stated.
The tie-up also enables end-to-end drug development for APIs (active pharmaceutical ingredients).
"This collaboration empowers clients with cutting-edge technologies, extensive product development expertise, and seamless scale-up capabilities," STEERLife CEO Indu Bhushan said.
The alliance exemplifies dedication to pushing boundaries, fostering growth and improving patient outcomes through transformative pharmaceutical solutions, Callidus Research Laboratories Co-founder & Director Vardhaman Bafna said.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Srestha Finvest
- 0.66 (+ 3.13)
- 52302633
- Vodafone Idea L
- 7.25 ( 0.00)
- 22381872
- Suzlon Energy Ltd.
- 62.37 (+ 5.00)
- 19753676
- AvanceTechnologies
- 0.95 ( -4.04)
- 18908878
- Standard Capital
- 1.05 (+ 5.00)
- 13415932
MORE NEWS
Social Media Cos Expected to Remove Violating...
India's IT Secretary expects social media companies to swiftly remove content that...
India, Russia Raise WTO Concerns Over Plastic...
India and Russia have expressed concerns about potential conflicts between future...
NLC Donates Rs 1 Crore to Kerala Disaster...
NLC India Ltd has contributed Rs 1 crore to the Kerala Disaster Mitigation Fund to...